Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 03/15: (CPXX) (SZYM) (ESI) Higher; (VRX) (LINE) (DDD) Lower (more...)

March 15, 2016 9:36 AM
Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) 409.5% HIGHER; announced positive results from the Phase 3 trial of VYXEOS (cytarabine: daunorubicin) Liposome ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles